Search Results

There are 40147 results for: content related to: Myelodysplastic syndrome incidence, transfusion dependence, health care use, and complications: an A ustralian population-based study 1998 to 2008

  1. You have free access to this content
    Multiparameter flow cytometry provides independent prognostic information in patients with suspected myelodysplastic syndromes: A study on 804 patients

    Cytometry Part B: Clinical Cytometry

    Volume 88, Issue 3, May/June 2015, Pages: 154–164, Wolfgang Kern, Ulrike Bacher, Claudia Haferlach, Tamara Alpermann, Susanne Schnittger and Torsten Haferlach

    Version of Record online : 24 MAR 2015, DOI: 10.1002/cyto.b.21224

  2. You have full text access to this OnlineOpen article
    Recent advances in myelodysplastic syndromes: Molecular pathogenesis and its implications for targeted therapies

    Cancer Science

    Volume 106, Issue 4, April 2015, Pages: 329–336, Hironori Harada and Yuka Harada

    Version of Record online : 25 FEB 2015, DOI: 10.1111/cas.12614

  3. You have free access to this content
    In patients with myelodysplastic syndromes with del(5q), factors other than age and sex contribute to the prognostic advantage, which diminishes over time

    British Journal of Haematology

    Volume 170, Issue 5, September 2015, Pages: 687–693, Michael Lauseker, Jennifer Schemenau, Corinna Strupp, Andrea Kündgen, Norbert Gattermann, Joerg Hasford and Ulrich Germing

    Version of Record online : 11 MAY 2015, DOI: 10.1111/bjh.13496

  4. You have free access to this content
    Altered neutrophil maturation patterns that limit identification of myelodysplastic syndromes

    Cytometry Part B: Clinical Cytometry

    Volume 82B, Issue 4, July 2012, Pages: 217–228, Sara A. Monaghan, Urvashi Surti, Ketah Doty and Fiona E. Craig

    Version of Record online : 19 MAR 2012, DOI: 10.1002/cyto.b.21016

  5. Does bleeding affect patient-reported outcome measures in patients with myelodysplasia or hematologic malignancies: a systematic review

    Transfusion

    Volume 54, Issue 4, April 2014, Pages: 1166–1179, Lise J. Estcourt, Deborah Pinchon, Emily Symington, Anne M. Kelly, Carolyn Doree, Susan Brunskill, Liz Glidewell and Simon Stanworth

    Version of Record online : 10 OCT 2013, DOI: 10.1111/trf.12441

  6. You have free access to this content
    Peripheral blood MDS score: A new flow cytometric tool for the diagnosis of myelodysplastic syndromes

    Cytometry Part B: Clinical Cytometry

    Volume 64B, Issue 1, March 2005, Pages: 9–17, Sindhu Cherian, Jonni Moore, Andrew Bantly, Jo-Anne Vergilio, Peter Klein, Selina Luger and Adam Bagg

    Version of Record online : 24 JAN 2005, DOI: 10.1002/cyto.b.20041

  7. Incidence of myelodysplastic syndromes in a Swedish population

    European Journal of Haematology

    Volume 54, Issue 3, March 1995, Pages: 153–156, Anders Rådlund, Torben Thiede, Sören Hansen, Magnus Carlsson and Leif Engquist

    Version of Record online : 24 APR 2009, DOI: 10.1111/j.1600-0609.1995.tb00206.x

  8. Deferasirox improves hematologic and hepatic function with effective reduction of serum ferritin and liver iron concentration in transfusional iron overload patients with myelodysplastic syndrome or aplastic anemia

    Transfusion

    Volume 54, Issue 6, June 2014, Pages: 1542–1551, June-Won Cheong, Hyeoung-Joon Kim, Kyoo-Hyung Lee, Sung-Soo Yoon, Jae Hoon Lee, Hee-Sook Park, Ho Young Kim, Hyeok Shim, Chu-Myung Seong, Chul Soo Kim, Jooseop Chung, Myung Soo Hyun, Deog-Yeon Jo, Chul Won Jung, Sang Kyun Sohn, Hwi-Joong Yoon, Byung Soo Kim, Young-Don Joo, Chi-Young Park, Yoo Hong Min and for the Korean Society of Hematology Acute Myeloid Leukemia/Myelodysplastic Syndrome Working Party

    Version of Record online : 3 DEC 2013, DOI: 10.1111/trf.12507

  9. You have free access to this content
    DNA microarray analysis of stage progression mechanism in myelodysplastic syndrome

    British Journal of Haematology

    Volume 123, Issue 2, October 2003, Pages: 288–296, Masuzu Ueda, Jun Ota, Yoshihiro Yamashita, Young Lim Choi, Ruri Ohki, Tomoaki Wada, Koji Koinuma, Yasuhiko Kano, Keiya Ozawa and Hiroyuki Mano

    Version of Record online : 6 NOV 2003, DOI: 10.1046/j.1365-2141.2003.04601.x

  10. You have free access to this content
    The impact of cytomorphology, cytogenetics, molecular genetics, and immunophenotyping in a comprehensive diagnostic workup of myelodysplastic syndromes

    Cancer

    Volume 115, Issue 19, 1 October 2009, Pages: 4524–4532, Ulrike Bacher, Torsten Haferlach, Wolfgang Kern, Tamara Weiss, Susanne Schnittger and Claudia Haferlach

    Version of Record online : 30 JUN 2009, DOI: 10.1002/cncr.24501

  11. You have free access to this content
    DIFFERENTIATION THERAPY OF MYELODYSPLASTIC SYNDROMES: FACT OR FICTION?

    British Journal of Haematology

    Volume 102, Issue 5, September 1998, Pages: 1124–1138, Valeria Santini and Pierluigi Rossi Ferrini

    Version of Record online : 9 OCT 2008, DOI: 10.1046/j.1365-2141.1998.00881.x

  12. Evolving trends in the treatment of low-risk myelodysplastic syndromes: immunomodulation and beyond—9th European Hematology Association Congress Geneva, Switzerland, 10–13 June 2004

    Transfusion Medicine

    Volume 17, Issue 3, June 2007, Pages: 151–160, P. Fenaux, J. M. Bennett, D. T. Bowen, R. D. Knight and A. F. List

    Version of Record online : 6 JUN 2007, DOI: 10.1111/j.1365-3148.2006.00681.x

  13. The Myelodysplastic Syndromes

    Postgraduate Haematology, Sixth edition

    Timothy JT Chevassut, Ghulam J Mufti, Pages: 503–529, 2010

    Published Online : 16 NOV 2010, DOI: 10.1002/9781444323160.ch28

  14. Smoking and alcohol and subsequent risk of myelodysplastic syndromes in Japan: the Japan Public Health Centre-based Prospective Study

    British Journal of Haematology

    Volume 178, Issue 5, September 2017, Pages: 747–755, Tomotaka Ugai, Keitaro Matsuo, Norie Sawada, Motoki Iwasaki, Taiki Yamaji, Taichi Shimazu, Shizuka Sasazuki, Manami Inoue, Yoshinobu Kanda, Shoichiro Tsugane and the Japan Public Health Centre-based Prospective Study Group

    Version of Record online : 17 JUL 2017, DOI: 10.1111/bjh.14749

  15. Age-related incidence and other epidemiological aspects of myelodysplastic syndromes

    British Journal of Haematology

    Volume 82, Issue 2, October 1992, Pages: 358–367, C. Aul, N. Gattermann and W. Schneider

    Version of Record online : 12 MAR 2008, DOI: 10.1111/j.1365-2141.1992.tb06430.x

  16. You have free access to this content
    Advances in the prognostication and management of advanced MDS in children

    British Journal of Haematology

    Volume 154, Issue 2, July 2011, Pages: 185–195, Henrik Hasle and Charlotte M. Niemeyer

    Version of Record online : 9 MAY 2011, DOI: 10.1111/j.1365-2141.2011.08724.x

  17. You have free access to this content
    The molecular pathogenesis of the myelodysplastic syndromes

    European Journal of Haematology

    Volume 95, Issue 1, July 2015, Pages: 3–15, Andrea Pellagatti and Jacqueline Boultwood

    Version of Record online : 20 FEB 2015, DOI: 10.1111/ejh.12515

  18. You have free access to this content
    A population-based study of childhood myelodysplastic syndrome in British Columbia, Canada

    British Journal of Haematology

    Volume 106, Issue 4, September 1999, Pages: 1027–1032, Henrik Hasle, Louis D. Wadsworth, Bonnie G. Massing, Mary McBride and Kirk R. Schultz

    Version of Record online : 25 DEC 2001, DOI: 10.1046/j.1365-2141.1999.01645.x

  19. Myelodysplastic syndrome in New Zealand and Australia

    Internal Medicine Journal

    Volume 42, Issue 11, November 2012, Pages: 1235–1242, E. J. Rodger and I. M. Morison

    Version of Record online : 19 NOV 2012, DOI: 10.1111/j.1445-5994.2011.02619.x

  20. You have free access to this content
    Myelodysplastic syndromes

    Cancer

    Volume 109, Issue 8, 15 April 2007, Pages: 1536–1542, Xiaomei Ma, Monique Does, Azra Raza and Susan T. Mayne

    Version of Record online : 7 MAR 2007, DOI: 10.1002/cncr.22570